Use Of Therapeutic Monoclonal Antibodies Increasing In Europe Despite high therapy costs and drug format limitations, the popularity of monoclonal antibodies (mAbs) is on the rise. Physicians are increasingly adopting mAbs because of their superior side effect profile, and continued research is expected to yield more innovative products. New analysis from
Source: www.medicalnewstoday.comUnibioscreen And Drais Pharmaceuticals Partner To Develop And Commercialize Unbs5162 For Treatment Of Cancer Drais Pharmaceuticals, Inc. and Unibioscreen S.A. announced that they have entered into a global agreement to develop and commercialize UNBS5162, one of Unibioscreen's investigational drug and potential breakthrough treatments for cancer. UNBS5162 was discovered by Unibioscreen and is currently in Phase I trials in the United States in cancer patients with advanced solid tumors or lymphoma.
Source: www.medicalnewstoday.comIRIN/PlusNews Examines Issues Surrounding Male Circumcision In Kenya's Luo Community Kenya's plan to launch a male circumcision campaign in the province of Nyanza in late September to curb the spread of HIV is facing difficulties from some members of the Luo community, IRIN/PlusNews reports.
Source: www.medicalnewstoday.comsimvastatin, Zocor Title: simvastatin, Zocor
Category: Medications
Created: 12/31/1997
Last Editorial Review: 9/16/2008
Source: www.medicinenet.com
# posted by Network @ 4:00 PM
